Regeneron's Antibody Combination Therapy Reduces COVID-19 Mortality Risk

Retrieved on: 2021-06-21 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Regeneron's Antibody Combination Therapy Reduces COVID-19 Mortality Risk. View article details on hiswai:

Excerpt

Results of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial have shown that Regeneron's investigational antibody combination ...

Article found on: www.biopharminternational.com